matmon

matmon | Joined since 2020-08-14

Investing Experience -
Risk Profile -

Followers

0

Following

1

Blog Posts

0

Threads

17

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
17
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2022-01-26 16:56 | Report Abuse

semalam panic bilis selling sebab order 100k dpt 100k bila turun kelam kabut ketakutan jatuh jadi papa kedana...sebab biasa order 100k dpt 10k shj paling tinggi. @serikaya


now time to push up

Stock

2020-12-01 20:17 | Report Abuse

Top Glove Working with Authorities to Improve Workers’ Accommodations

Shah Alam, Tuesday,

1 December 2020 With regard to the news announcement by the
Ministry of Human Resources, relating to the Workers' Minimum Standards of Housing and
Amenities Act 1990 (Act 446), we wish to inform that Top Glove will be extending its fullest
cooperation to the relevant authorities on the matter.
Top Glove wishes to clarify that efforts to source for more accommodation and to improve
existing worker accommodations are ongoing, in view of the large number of workers we
employ. We expect to complete the exercise of improving workers’ accommodation around
31st December 2020. This is in line with the government’s educational approach on employers
in various sectors until the end of this year (2020), so that they can comply with Act 446. Kindly
refer to the news report dated 8th September 2020 carried by Bernama and The Sun Daily as per
following links:

https://www.bernama.com/en/general/news.php?id=1877719 and
https://www.thesundaily.my/local/act-446-government-adopts-educational-approach-untildecember-LH3911805.

The Company has spent some RM20 million on purchasing 100 units of apartments for workers
over the past two months, to ensure that they adhere to the Government’s requirements. This is
in addition to having previously invested in 100 double storey houses and hostels with full
facilities including in-house canteen, automated teller machines, barbershops, and minimarts,
worth an estimated RM50 million in total.
Our workforce is the Company’s greatest asset, and we are committed to continue working
closely with the relevant authorities to make the necessary improvements towards ensuring the
safety, health and well-being of our employees.

Stock

2020-11-14 23:17 | Report Abuse

Tradeview Commentaries 14th November 2020 - Unwavering Confidence In Glove Makers In Spite of Vaccine Newsflow

Dear all my friends who celebrates, happy Deepavali. May this joyous occasion be celebrated with your loved ones.

The market sentiment over the week was a mixture of anxiety and joy. Joy for those who believed in value stocks and blue chips, whereby it surged tremendously. Anxiety however, are for investors of glove, PPE and related stocks which reacted adversely due to the news of Pfizer vaccine.

On a positive note, following US elections and Pfizer vaccine news, foreign funds have been flowing back to Malaysia for 3 consecutive days and even exceeded 20% overall market participation level.

In the coming weeks, there will be more vaccine news. It will likely be Moderna and Astra Zeneca to follow. Potentially, China vaccines will also come through with their phase 3 safety data.

In this case, it will bode well for Value stocks (Banks, select blue chips) and Legitimate Vaccine related companies

How about glove, is it all over?

Through the year, I have done many site visits personally and met with management of key industry players, even spoke with established distributors. Whatever I have shared are not information pluck from the sky based on airy fairy hopes but on objective facts. I will update all my latest view post-Pfizer announcement.

1. Earnings visibility for gloves are still at least 12 month / 1 full year through 2021. (This is not a disputed fact even by the most bearish analyst for the sector. )

2. Vaccine or no vaccine, ASP and demand won’t fall off the cliff. (Again not disputed fact even by the most bearish analyst)

3. Mass vaccination will take time, and implementation for the world even longer. At the very least 1 year. (This is a fact stated by WHO & Dr. Fauci.)

4. Glove strong demand due to severe shortage will last through to 2022. New hygiene practice and structural step up, increased healthcare budget for governments around the world and stockpiling requirements contributes to this. (This is a fact)

5. Potential future oversupply concern. (Two camps arguing with 1 side arguing due to new entrants there will be oversupply but I don’t believe this as new entrants can’t compete with established players due to certification, safety standards, economies of scale and technical know how)

6. Eventual decline in mid 2022/2023 for ASP and demand (strongest argument for glove bears. My view - I can’t tell what happens in 18 / 24 months. No one can. As the time progresses, more visibility comes through. But I believe ASP will plateau later than sooner, definitely this year)

7. Glove stocks are overvalued. This is are noises by naysayers and bears. No matter which method I adopted, PER multiples against past year Standard Deviation, DCF or the most accurate EV/EBITDA (EV ratio), dividend yield forecast, gloves stocks are undervalued and a far mile from being overvalued. This is a fact. If analysts are objective and fair in their assessment for all companies in Bursa using the same stringent assessment scrutinising glove stocks, there will be absolutely no companies that we can buy or invest anymore. Tech stocks are by far grossly overvalued, recovery stocks like airlines / tourism are taking into account future earnings which does not exist, local vaccine related stocks with MOU has no proof of ability to deliver as the best vaccines are taken up.

In a nutshell, I think some investors and select funds are overly conservative in valuing glove stocks. They are worried being caught as the last one holding the stocks choosing to forego 1 full years of record Profits and potential bumper dividend.

Use this opportunity to buy on weakness. When value emerges ignore the noises. I think Riverstone, Hartalega, Top Glove, Supermax, Sri Trang, Kossan are good fundamental companies worth a place in your portfolio regardless of the “overnight vaccine experts” who think otherwise.

Stock

2020-11-14 23:15 | Report Abuse

Tradeview Commentaries 14th November 2020 - Unwavering Confidence In Glove Makers In Spite of Vaccine Newsflow

Dear all my friends who celebrates, happy Deepavali. May this joyous occasion be celebrated with your loved ones.

The market sentiment over the week was a mixture of anxiety and joy. Joy for those who believed in value stocks and blue chips, whereby it surged tremendously. Anxiety however, are for investors of glove, PPE and related stocks which reacted adversely due to the news of Pfizer vaccine.

On a positive note, following US elections and Pfizer vaccine news, foreign funds have been flowing back to Malaysia for 3 consecutive days and even exceeded 20% overall market participation level.

In the coming weeks, there will be more vaccine news. It will likely be Moderna and Astra Zeneca to follow. Potentially, China vaccines will also come through with their phase 3 safety data.

In this case, it will bode well for Value stocks (Banks, select blue chips) and Legitimate Vaccine related companies

How about glove, is it all over?

Through the year, I have done many site visits personally and met with management of key industry players, even spoke with established distributors. Whatever I have shared are not information pluck from the sky based on airy fairy hopes but on objective facts. I will update all my latest view post-Pfizer announcement.

1. Earnings visibility for gloves are still at least 12 month / 1 full year through 2021. (This is not a disputed fact even by the most bearish analyst for the sector. )

2. Vaccine or no vaccine, ASP and demand won’t fall off the cliff. (Again not disputed fact even by the most bearish analyst)

3. Mass vaccination will take time, and implementation for the world even longer. At the very least 1 year. (This is a fact stated by WHO & Dr. Fauci.)

4. Glove strong demand due to severe shortage will last through to 2022. New hygiene practice and structural step up, increased healthcare budget for governments around the world and stockpiling requirements contributes to this. (This is a fact)

5. Potential future oversupply concern. (Two camps arguing with 1 side arguing due to new entrants there will be oversupply but I don’t believe this as new entrants can’t compete with established players due to certification, safety standards, economies of scale and technical know how)

6. Eventual decline in mid 2022/2023 for ASP and demand (strongest argument for glove bears. My view - I can’t tell what happens in 18 / 24 months. No one can. As the time progresses, more visibility comes through. But I believe ASP will plateau later than sooner, definitely this year)

7. Glove stocks are overvalued. This is are noises by naysayers and bears. No matter which method I adopted, PER multiples against past year Standard Deviation, DCF or the most accurate EV/EBITDA (EV ratio), dividend yield forecast, gloves stocks are undervalued and a far mile from being overvalued. This is a fact. If analysts are objective and fair in their assessment for all companies in Bursa using the same stringent assessment scrutinising glove stocks, there will be absolutely no companies that we can buy or invest anymore. Tech stocks are by far grossly overvalued, recovery stocks like airlines / tourism are taking into account future earnings which does not exist, local vaccine related stocks with MOU has no proof of ability to deliver as the best vaccines are taken up.

In a nutshell, I think some investors and select funds are overly conservative in valuing glove stocks. They are worried being caught as the last one holding the stocks choosing to forego 1 full years of record Profits and potential bumper dividend.

Use this opportunity to buy on weakness. When value emerges ignore the noises. I think Riverstone, Hartalega, Top Glove, Supermax, Sri Trang, Kossan are good fundamental companies worth a place in your portfolio regardless of the “overnight vaccine experts” who think otherwise.

Stock

2020-10-22 17:12 | Report Abuse

anyone know when qr report out ?

Stock

2020-10-01 19:08 | Report Abuse

Have been following this r88. His technical analysis is mostly correct.

No right or wrong. As long know the counter have potential up

Is safe to go in and out with technical . But need time to monitor.

Of FA play keep average down but need guts to hold.

Stock

2020-08-28 19:54 | Report Abuse

Dear mr ythih . Can I request for your kindness to join the group discussion. As have requesr few times .

Really appreciate. Will contribute post also

Stock

2020-08-28 19:08 | Report Abuse

a
ccording to a fund manager with a local asset management firm, there would be some buying interest in companies to be included in the MSCI Index but the change is likely to have been priced in as non-index linked funds would have bought into the market prior to the rebalancing. The inclusions and deletions were revealed on May 14.

“Similarly, we will usually see a selldown on those that will be removed from the list prior to the changes taking place. Of course, we’ll still see some of these buying and selling patterns at the opening half of the market if there are no other events affecting the market,” he said.

Danny Wong, chief executive officer of Areca Capital Sdn Bhd agreed, saying that there will be a one-off impact as some index tracking fund may follow the index constituents by buying into them.

Stock

2020-08-28 19:04 | Report Abuse

for new stocks entry kossan and supermax would see the price increase as new stock entry into the index, the fund manager have to buy the shift the shares from remove stocks to the new entry stocks.

" Each index in the MSCI family is reviewed quarterly and rebalanced twice a year. Stocks are added or removed from an index by analysts within MSCI to ensure that the index still acts as an effective equity benchmark for the market it represents. When an MSCI index is rebalanced, ETFs and mutual funds must also adjust their fund holdings since they are created to mirror the performance of the indexes. "

therefore for msci addition supermax and kossan would benefit more

News & Blogs

2020-08-25 22:39 | Report Abuse

hi would like to join the discussion group

Stock

2020-08-19 00:12 | Report Abuse

Dear ythits. If I can join the discussion group. Really appreciate

News & Blogs

2020-08-19 00:10 | Report Abuse

Tq sifu free to speak superb

Stock

2020-08-18 20:54 | Report Abuse

Harta pe 100. Supeemax 50. And top glove is price rm 30 before ex. And expected sept pat 1000. The pe will be 50.

So which is more upside ?

Stock

2020-08-14 21:36 | Report Abuse

Dear @ytthihs. Can invite me. Yes tired of people trolling around.

We come here to share information. Not to spam and bashing.

I am done here.

Please can add me dear yttihs